Article

RNAse-free manufacture of Venezuelan Equine Encephalitis Virus (VEEV) plasmid DNA vaccine

2025-05-23

Abstract excerpt

The long shelf-life and stability of DNA makes this platform highly attractive for low-cost, rapid delivery of pandemic response vaccines. Protocols utilized for clinical grade plasmid manufacture by contract development and manufacturing organizations are not readily accessible to academic and public research laboratories engaged in early-phase plasmid vaccine development. We present here the framework for DNA ma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d493b032-bcd6-5799-8906-19f3727410d6
DOI: 10.1101/2025.05.22.655656

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

RNAse-free manufacture of Venezuelan Equine Encephalitis Virus (VEEV) plasmid DNA vaccineDOI 10.1101/2025.05.22.655656Read

Evaluation of Vibrio natriegens as a fast-growing alternative host for plasmid DNA productionSemantic proximity Read

miniVec: A miniaturized plasmid backbone supporting antibiotic-free and additive-free fermentation with enhanced yield and functionalitySemantic proximity Read

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact componentsSemantic proximity Read

Design of flowsheets for the recovery and purification of plasmids for gene therapy and DNA vaccinationSemantic proximity Read

Vector Design for Improved DNA Vaccine Efficacy, Safety and ProductionSemantic proximity Read

Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapySemantic proximity Read

Plasmid DNA Manufacturing for Indirect and Direct Clinical ApplicationsSemantic proximity Read

Immunogenicity of COVID-eVax Is Moderately Impacted by Temperature and Molecular IsoformsSemantic proximity Read

Maximization of the Minicircle DNA Vaccine Production Expressing SARS-CoV-2 RBDSemantic proximity Read

Plasmid DNA fermentation strain and process‐specific effects on vector yield, quality, and transgene expressionSemantic proximity Read

Quantification of residual plasmid DNA and SV40 promoter-enhancer sequences in Pfizer/BioNTech and Moderna modRNA COVID-19 vaccines from Ontario, CanadaSemantic proximity Read

Purification of plasmid DNA for use in human gene therapySemantic proximity Read